Nalu Medical, Inc.

Nalu Medical, Inc. is a standout in the health care industry, headquartered in Carlsbad, California. Since its founding in 2014, the company has continued to make waves with its innovative approach. Their flagship product, the Nalu neurostimulation system, stands out as a battery-free, micro-implantable pulse generator (iPG) that received FDA clearance for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) to alleviate chronic pain. The system's exceptional capabilities and ease of upgradability set it apart, offering a diverse menu of therapy options. In a recent milestone, Nalu Medical, Inc. attracted a significant $85.00M Series E investment on 03 January 2024. This funding round saw participation from a prominent group of investors, including Novo Holdings, Advent Life Sciences, Longitude Capital, Pura Vida Investments, Aperture Venture Partners, Gilde Healthcare, Decheng Capital, Endeavour Vision, and MVM Partners. This substantial investment underscores the confidence and support from key players in the investment landscape. Nalu Medical, Inc.'s commitment to pioneering technology and its strong financial backing positions the company for continued growth and success in the evolving healthcare landscape. With a robust foundation and a strong network of investors, the company is engineered to be more and poised to make a lasting impact in the medical device industry.